NovaBridge Biosciences: common_shares_outstanding
| Value | {"unit": "shares", "value": 185613662, "concept": "us-gaap:CommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2023-12-31) |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bcd8a7f1-5ec6-42d6-b86e-18a790e491a0
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001104659-24-054452Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/common-shares-outstanding/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bcd8a7f1-5ec6-42d6-b86e-18a790e491a0
History
- no predecessors — first report